Intraneuronal Aβ42 Accumulation in Human Brain

The American Journal of Pathology - Tập 156 Số 1 - Trang 15-20 - 2000
Gunnar K. Gouras1,2,3, Julia Tsai1, Jan Näslund2,3, Bruno Vincent2,3, Mark Edgar4, Frédéric Checler5, Jeffrey P. Greenfield2,3, Vahram Haroutunian6, Joseph D. Buxbaum6, Huaxi Xu2,3, Paul Greengard2,3, Norman Relkin1
1Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York
2Fisher Center for Research on Alzheimer's Disease, The Rockefeller University, New York, New York
3Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, New York
4Department of Pathology, Weill Medical College of Cornell University, New York, New York
5Institute de Pharmacologie Moleculaire et Cellulaire, Valbonne, France
6Mount Sinai School of Medicine, New York, New York;

Tóm tắt

Từ khóa


Tài liệu tham khảo

Selkoe, 1998, The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease, Trends Cell Biol, 8, 447, 10.1016/S0962-8924(98)01363-4

Iwatsubo, 1994, Visualization of A β 42(43) and A β 40 in senile plaques with end-specific A β monoclonals: evidence that an initially deposited species is A β 42(43), Neuron, 13, 45, 10.1016/0896-6273(94)90458-8

Lemere, 1996, Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation, Neurobiol Dis, 3, 16, 10.1006/nbdi.1996.0003

Xu, 1997, Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation, Proc Natl Acad Sci USA, 94, 3748, 10.1073/pnas.94.8.3748

Wild-Bode, 1997, Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42, J Biol Chem, 272, 16085, 10.1074/jbc.272.26.16085

Skovronsky, 1998, Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture, J Cell Biol, 141, 1031, 10.1083/jcb.141.4.1031

Hartmann, 1997, Distinct sites of intracellular production for Alzheimer's disease A β40/42 amyloid peptides, Nat Med, 3, 1016, 10.1038/nm0997-1016

Cook, 1997, Alzheimer's A β(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells, Nat Med, 3, 1021, 10.1038/nm0997-1021

Greenfield, 1999, Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer β-amyloid peptides, Proc Natl Acad Sci USA, 96, 742, 10.1073/pnas.96.2.742

Perez, 1999, Mutagenesis identifies new signals for β-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42, J Biol Chem, 274, 18851, 10.1074/jbc.274.27.18851

Chui, 1999, Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation, Nat Med, 5, 560, 10.1038/8438

Stern, 1989, Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease β-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system, Am J Pathol, 134, 973

Mak, 1994, Polyclonals to β-amyloid(1–42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum, Brain Res, 667, 138, 10.1016/0006-8993(94)91725-6

LaFerla, 1997, Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization, J Clin Invest, 100, 310, 10.1172/JCI119536

Masters, 1985, Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels, EMBO J, 4, 2757, 10.1002/j.1460-2075.1985.tb04000.x

Hyman, 1989, A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles, Neurosci Lett, 101, 352, 10.1016/0304-3940(89)90559-4

Allsop, 1990, Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid β-protein of Alzheimer's disease, Am J Pathol, 136, 255

Hyman, 1986, Perforant pathway changes and the memory impairment of Alzheimer's disease, Ann Neurol, 20, 472, 10.1002/ana.410200406

Barelli, 1997, Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases, Mol Med, 3, 695, 10.1007/BF03401708

Gouras, 1998, Generation and regulation of amyloid-β peptide variants in neurons, J Neurochem, 71, 1920, 10.1046/j.1471-4159.1998.71051920.x

Borchelt, 1996, Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1–42/1–40 ratio in vitro and in vivo, Neuron, 17, 1005, 10.1016/S0896-6273(00)80230-5

Saido, 1995, Dominant and differential deposition of distinct β-amyloid peptide species, A β N3(pE), in senile plaques, Neuron, 14, 457, 10.1016/0896-6273(95)90301-1

Xu, 1998, Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides, Nat Med, 4, 447, 10.1038/nm0498-447

Stieber, 1996, In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic, Am J Pathol, 148, 415

Guo, 1998, Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease, Nat Med, 4, 957, 10.1038/nm0898-957

Hsia, 1999, Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models, Proc Natl Acad Sci USA, 96, 3228, 10.1073/pnas.96.6.3228

Moechars, 1999, Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain, J Biol Chem, 274, 6483, 10.1074/jbc.274.10.6483

Bales, 1997, Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition, Nat Genet, 17, 263, 10.1038/ng1197-263